Literature DB >> 18841451

Peripherally induced Treg: mode, stability, and role in specific tolerance.

Irina Apostolou1, Panos Verginis, Karsten Kretschmer, Julia Polansky, Jochen Hühn, Harald von Boehmer.   

Abstract

Foxp3-expressing regulatory T cells (Treg) have an essential function of preventing autoimmune disease in man and mouse. Foxp3 binds to forkhead motifs of about 1,100 genes and the strength of binding increases upon phorbol 12-myristate 13-acetate/ionomycin stimulation. In Foxp3-expressing T cell hybridomas, Foxp3 promoter binding does not lead to activation or suppression of genes which becomes only visible after T cell activation. These findings are in line with observations by others that Foxp3 exerts important functions in collaboration with T cell receptor (TCR)-dependent transcription factors in a DNA-binding complex. Tregs can be generated when developing T cells encounter TCR agonist ligands in the thymus. This process apparently depends on costimulatory signals. In contrast, extrathymic conversion of naïve T cells into Tregs appears to depend on transforming growth factor (TGF)-beta and is inhibited by costimulation. In fact, dendritic cell-derived retinoic acid helps the conversion process by counteracting the negative impact of costimulation. Tregs induced by subimmunogenic antigen delivery in vivo are much more stable than Tregs induced by antigenic stimulation in the presence of TGF-beta in vitro which correlates with the extent of demethylation of the Foxp3 locus. Tregs can be induced by conversion of antigen-specific T cells that occur with a very low frequency in wt mice. Conversion of naïve cluster of differentiation (CD)4 T cells into Tregs by a single peptide of HY antigens results in complete antigen-specific tolerance to an entire set of HY epitopes recognized by CD4 as well as CD8 T cells when presented with male skin or hemopoietic grafts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841451     DOI: 10.1007/s10875-008-9254-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.

Authors:  M Itoh; T Takahashi; N Sakaguchi; Y Kuniyasu; J Shimizu; F Otsuka; S Sakaguchi
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development.

Authors:  Harald von Boehmer
Journal:  Adv Immunol       Date:  2004       Impact factor: 3.543

3.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

4.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

5.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

6.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

8.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

9.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

10.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  26 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

2.  Regulatory T cells that become autoaggressive.

Authors:  Daniel Hawiger; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-09       Impact factor: 25.606

3.  Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability.

Authors:  Jee H Lee; John P Lydon; Chang H Kim
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

4.  Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.

Authors:  Michael W Y Chan; Chia-Bin Chang; Chien-Hsueh Tung; Justin Sun; Jau-Ling Suen; Shu-Fen Wu
Journal:  Mol Med       Date:  2014-06-26       Impact factor: 6.354

Review 5.  Cancer immunotherapy: sipuleucel-T and beyond.

Authors:  Aimee E Hammerstrom; Diana H Cauley; Bradley J Atkinson; Padmanee Sharma
Journal:  Pharmacotherapy       Date:  2011-08       Impact factor: 4.705

6.  Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.

Authors:  V Di Caro; A D'Anneo; B Phillips; C Engman; J Harnaha; R Lakomy; A Styche; M Trucco; N Giannoukakis
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

7.  Local "on-demand" generation and function of antigen-specific Foxp3+ regulatory T cells.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

8.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

9.  The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.

Authors:  Aisling O'Hara Hall; Daniel P Beiting; Cristina Tato; Beena John; Guillaume Oldenhove; Claudia Gonzalez Lombana; Gretchen Harms Pritchard; Jonathan S Silver; Nicolas Bouladoux; Jason S Stumhofer; Tajie H Harris; John Grainger; Elia D Tait Wojno; Sagie Wagage; David S Roos; Philip Scott; Laurence A Turka; Sara Cherry; Steven L Reiner; Daniel Cua; Yasmine Belkaid; M Merle Elloso; Christopher A Hunter
Journal:  Immunity       Date:  2012-09-13       Impact factor: 31.745

10.  TGF-beta and 'adaptive' Foxp3(+) regulatory T cells.

Authors:  Wanjun Chen; Joanne E Konkel
Journal:  J Mol Cell Biol       Date:  2009-07-31       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.